Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...

Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Read more ...

Hims & Hers stock price continues to fire on all cylinders this year and is hovering near its highest level on record. It has ...

We recently published a list of 12 Best Beauty Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

According to a report by McKinsey, in 2023, the global beauty market expanded by 10%, reaching $446 billion in retail sales, ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

Hims, Inc. is a telehealth company, primarily targets men's wellness and healthcare. The company offers treatments for issues like hair loss and erectile dysfunction. Hims leverages online ...